Home > Healthcare > Corneal Pachymetry Market

Corneal Pachymetry Market Analysis

  • Report ID: GMI8691
  • Published Date: Mar 2024
  • Report Format: PDF

Corneal Pachymetry Market Analysis

Based on product type, the market is segmented into handheld and desktop. The handheld segment is anticipated to reach USD 431 million by 2032.
 

  • Handheld devices offer portability and ease of use, allowing healthcare providers to perform corneal thickness measurements conveniently at various points of care, including outpatient clinics, primary care offices, and remote locations. This portability is particularly advantageous for practitioners who require mobility during patient examinations.  
     
  • Moreover, handheld corneal pachymeters may be more cost-effective than their desktop counterparts, making them a preferred choice for healthcare providers operating within constrained budgets, such as small clinics or rural healthcare facilities. The lower initial investment and maintenance costs associated with handheld devices contribute to their increasing adoption.  
     

Based on technology, the corneal pachymetry market is segmented into ultrasonic pachymetry, optical pachymetry and scheimpflug imaging pachymetry. The ultrasonic pachymetry segment held leading revenue of USD 227.1 million in 2023 and is anticipated to witness with a healthy growth rate over the forecast period.
 

  • Ultrasonic pachymetry has been widely regarded as the gold standard for corneal thickness measurements due to its high accuracy and reliability. It provides precise measurements of corneal thickness, making it invaluable for various ophthalmic applications, including preoperative assessment for refractive eye surgery and glaucoma treatment.
     
  • Moreover, ultrasonic pachymetry devices are widely and easily available with range of options offered by multiple manufacturers. They come in different configurations and price ranges, making them accessible to healthcare providers with diverse budgetary constraints.
     

Based on application, the corneal pachymetry market is segmented into glaucoma diagnosis, refractive surgery, keratoconus treatment monitoring and other applications. The glaucoma diagnosis segment was valued around USD 180.6 million in 2023.
 

  • Elevated intraocular pressure (IOP) is a key risk factor for glaucoma. Corneal pachymetry helps in accurately measuring central corneal thickness, which in turn allows for more accurate diagnosis and interpretation of IOP measurements. Hence, the above factors may contribute significantly to the segment growth.
     
  • Moreover, growing awareness about the importance of regular eye examinations and screening for glaucoma has led to an increase in the number of individuals seeking diagnostic services. Healthcare organizations and advocacy groups often organize screening programs to detect glaucoma in its early stages, further driving demand for glaucoma diagnosis tests.
     

Corneal Pachymetry Market, by End-use, (2023)

The corneal pachymetry market by end-use is categorized into hospitals, specialty clinics, and other end-users. The hospital segment dominates the market with the revenue of around USD 189.9 million in 2023.
 

  • Hospitals, serving as primary healthcare facilities for a significant portion of the population, regularly cater to a diverse patient demographic, including those with intricate eye conditions necessitating specialized care. Given the substantial patient influx in hospitals, there's a vital need for advanced corneal pachymetry devices to meet the growing demand for diagnostic services.
     
  • Furthermore, hospitals play a pivotal role as centers for medical research and innovation, particularly in the realm of ophthalmic diagnostics and treatments. They offer the essential infrastructure and resources crucial for supporting research endeavors, thus positioning them as major end users of such advanced diagnostic devices.
     

North America Corneal Pachymetry Market, 2021- 2032 (USD Million)

North America corneal pachymetry market accounted for USD 234.3 million revenue in 2023 and is anticipated to record substantial market growth.
 

  • The region is experiencing a rise in the prevalence of eye disorders such as, keratoconus, and refractive errors. Corneal pachymetry plays a crucial role in the diagnosis and management of these conditions, thereby driving the demand for corneal pachymetry devices.  
     
  • Furthermore, there is a growing emphasis on preventive healthcare in North America, including regular eye examinations as part of preventive care routines. This increased focus on preventive care solutions may contribute to the growing demand for this diagnostic procedures.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Corneal pachymetry market size was USD 420.5 million in 2023 and is expected to register 5.8% CAGR from 2024-2032 owing to the rise in the prevalence of eye disorders such as glaucoma and diabetic retinopathy worldwide.

The handheld segment is expected to reach USD 431 million by 2032 due to their ability for portability and ease of use, allowing healthcare providers to perform corneal thickness measurements more conveniently.

North America corneal pachymetry industry reached USD 234.3 million in 2023 and is expected to register a commendable CAGR from 2024-2032 due to the rise in the prevalence of eye disorders such as, keratoconus, and refractive errors in the region.

Carl Zeiss Meditech AG, DGH Technology, Inc, Kxele.com, Lumibird, NIDEK CO., LTD., Reichert Inc., Sonomed Escalon, TOMEY CORPORATION, Topcon Corporation, and Visionix, are some of the major corneal pachymetry companies worldwide.

Corneal Pachymetry Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 248
  • Countries covered: 22
  • Pages: 130
 Download Free Sample